(Corrects to remove reference to attributable profit in lead paragraph)
JD Health International (HKG:6618) recorded a 78% rise in profit in the first quarter of 2026 to 1.66 billion yuan from 934.4 million yuan a year prior, according to a Tuesday Hong Kong bourse filing.
The online healthcare platform's revenue for the three months jumped 17% to 19.47 billion yuan from 16.65 billion yuan in the prior-year period.
The company is also planning to buy back up to $1 billion of shares from the open market over 48 months, pending approval, according to a separate stock exchange filing.